NCT00557102View on ClinicalTrials.gov

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Colorectal CancerMetastatic Cancer

Interventions

BIOLOGICAL

cetuximab

BIOLOGICAL

filgrastim

DRUG

fluorouracil

DRUG

irinotecan hydrochloride

DRUG

leucovorin calcium

Trial Locations (1)

38043

CHU de Grenoble - Hopital Michallon, Grenoble

All Listed Sponsors

collaborator

University Hospital, Grenoble

OTHER

lead

National Cancer Institute, France

OTHER_GOV

NCT00557102 - Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung | Biotech Hunter | Biotech Hunter